Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted January 15, 2004 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

[url=http://www.dtcuba.com]http://www.dtcuba.com[/url]

Havana.- Cuba’s health system this year began administering a new Cuban-made vaccine against the Haemofilus Influenza.

The synthetic vaccine, the only one of its kind in the world, also protects children against sepsis and rheumatoid arthritis.

Clinical trials proved that the vaccine is safe, has a great immune effect, can generate the antibodies that children need to be protected against the disease, and its efficacy rate is above 99 percent.

The vaccine was developed by the Center for Research on Synthetic Antigens, attached to the University of Havana.

The company Heber Biotec is in charge of producing and commercializing the vaccine.

Would you like to add more information?


Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
Images of Cuba
BIG yellow American chrome classic car
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review



Member of the Association for the Study of the Cuban Economy